Aeglea Biotherapeutics shares owned by ADAR1 Capital Management
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by ADAR1 Capital Management
from 13F filings
Historical chart of ADAR1 Capital Management investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Aeglea Biotherapeutics by ADAR1 Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $571k | 34k | 16.76 |
| 2025-06-30 | $510k | 34k | 14.97 |
| 2025-03-31 | $243k | 15k | 16.14 |
| 2024-09-30 | $369k | 13k | 29.41 |
| 2024-06-30 | $827k | 35k | 23.51 |
| 2024-03-31 | $1.9M | 50k | 37.93 |
| 2023-12-31 | $139k | 6.4k | 21.52 |